4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-004476
CVP, Chief Financial Officer sold 13,000 shares at an average $80.04 ($1,040,544)
- CVP, Chief Financial Officer acquired 13,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2026-04-09 | Option exercise 10b5-1 | +13,000 | $59.26 | $770,337 | 52,699 | D: show line 1 in the form |
| Ullem Scott B. CVP, Chief Financial Officer | 2026-04-09 | Sale 10b5-1 | −4,676 | $80.50 | $376,401 | 48,023 | D: show line 2 in the form |
| Ullem Scott B. CVP, Chief Financial Officer | 2026-04-09 | Sale 10b5-1 | −8,324 | $79.79 | $664,144 | 39,699 | D: show line 3 in the form |
| Open-market sales · 13,000 sh · avg $80.04 · $1,040,544 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2026-04-09 | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 13,000 | D: show line 4 in the form |
Loading xslF345X06/doc4.xml…